SUBCHAPTER C—DRUGS: GENERAL (parts 200 to 299)
- PART 200—GENERAL
- PART 201—LABELING
- PART 202—PRESCRIPTION DRUG ADVERTISING
- PART 203—PRESCRIPTION DRUG MARKETING
- PART 205—GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS
- PART 206—IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
- PART 207—REGISTRATION OF PRODUCERS OF DRUGS AND LISTING OF DRUGS IN COMMERCIAL DISTRIBUTION
- PART 208—MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
- PART 209—REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
- PART 210—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
- PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
- PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- PART 216—PHARMACY COMPOUNDING
- PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
- PART 226—CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
- PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
- PART 290—CONTROLLED DRUGS
- PART 299—DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES